These authors demonstrated that TGF-β1 inhibition increases in vitro BC radiosensitivity and promotes in vivo tumour control by radiation, once again highlighting the relevance of this immune biomarker evaluation during cancer IR treatment. Here, TGFB1 is linked to neoplasm.